Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
St. Jude Medical launches new study of next-gen multi-point cardiac pacing
St. Jude Medical (NYSE:STJ) enrolled the 1st patient in a clinical study evaluating pacing in multiple points on the heart, the company announced today.
Diabetes: Insulet and Eli Lilly team up for specialty insulin pump
Abiomed gains on surging FY2013 profits
Abiomed (NSDQ:ABMD) shares gained nearly 7% this morning after the medical device company reported profit growth in excess of 900%, beating Wall Street’s earnings expectations along the way.
The Danvers, Mass.-based heart pump maker reported fiscal 2013 profits of $15.0 million, or 38¢ per share, on sales of $157.6 million, for a whopping bottom-line gain of 904.3% on top-line growth of 25.8%.
Cynosure’s Q1 earnings miss expectations
LeMaitre Vascular ticks up on 120% Q1 profit jump
Profits soared 120% for LeMaitre Vascular (NSDQ:LMAT) during the 1st quarter on its 2nd consecutive quarter of double-digit sales growth, as the medical device company beat Wall Street’s earnings expectations by a penny.
Abiomed: Costs of Impella heart pump come in well below national standards
Diabetes: Medtronic partners with China to develop care for Type I diabetics
Hospira slides after taking $134M charge on infusion pump phase-out
Wright Medical slides into Q1 red, still beats The Street
CORRECTED May 2, 2013 at 12:30 p.m. This article originally mis-stated the nature of an expected insurance settlement and of Wright’s adjusted earnings-per-share forecast.
NuVasive’s Q1 sales rise, profits surge as it settles beef with Medtronic
Investors failed to reward NuVasive Inc. (NSDQ:NUVA) for reporting mid-single-digit sales growth and double-digit profit growth during the 1st quarter, sending shares down slightly today on Wall Street after the medical device company lowered its full-year earnings forecast.